Responses

Download PDFPDF

Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    An unusual case of haematuria

    Dear Editor,

    Your study reports an incidence of 7.8% nephrolithiasis occurring in a sample of 51 children treated with a 7 day course of normal or high dose ceftriaxone.[1] The renal stones were small sized (2mm) and asymptomatic, detected by abdominal USS. Ceftriaxone is known to bind with calcium ions and form insoluble precipitates leading to biliary pseudolithiasis. As the kidneys eliminate approximately 33-67%...

    Show More
    Conflict of Interest:
    None declared.